Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

医学 低磷血症 缺铁性贫血 缺铁 贫血 胃肠病学 内科学
作者
Myles Selig Wolf,Janet E. Rubin,Maureen Achebe,Michael J. Econs,Munro Peacock,Erik Allen Imel,Lars L. Thomsen,Thomas O. Carpenter,Thomas Joseph Weber,Vincent Mathias Brandenburg,Heinz Zoller
出处
期刊:JAMA [American Medical Association]
卷期号:323 (5): 432-432 被引量:335
标识
DOI:10.1001/jama.2019.22450
摘要

Importance: Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23-mediated hypophosphatemia. Objective: To compare risks of hypophosphatemia and effects on biomarkers of mineral and bone homeostasis of intravenous iron isomaltoside (now known as ferric derisomaltose) vs ferric carboxymaltose. Design, Setting, and Participants: Between October 2017 and June 2018, 245 patients aged 18 years and older with iron-deficiency anemia (hemoglobin level ≤11 g/dL; serum ferritin level ≤100 ng/mL) and intolerance or unresponsiveness to 1 month or more of oral iron were recruited from 30 outpatient clinic sites in the United States into 2 identically designed, open-label, randomized clinical trials. Patients with reduced kidney function were excluded. Serum phosphate and 12 additional biomarkers of mineral and bone homeostasis were measured on days 0, 1, 7, 8, 14, 21, and 35. The date of final follow-up was June 19, 2018, for trial A and May 29, 2018, for trial B. Interventions: Intravenous administration of iron isomaltoside, 1000 mg, on day 0 or ferric carboxymaltose, 750 mg, infused on days 0 and 7. Main Outcomes and Measures: The primary end point was the incidence of hypophosphatemia (serum phosphate level <2.0 mg/dL) between baseline and day 35. Results: In trial A, 123 patients were randomized (mean [SD] age, 45.1 [11.0] years; 95.9% women), including 62 to iron isomaltoside and 61 to ferric carboxymaltose; 95.1% completed the trial. In trial B, 122 patients were randomized (mean [SD] age, 42.6 [12.2] years; 94.1% women), including 61 to iron isomaltoside and 61 to ferric carboxymaltose; 93.4% completed the trial. The incidence of hypophosphatemia was significantly lower following iron isomaltoside vs ferric carboxymaltose (trial A: 7.9% vs 75.0% [adjusted rate difference, -67.0% {95% CI, -77.4% to -51.5%}], P < .001; trial B: 8.1% vs 73.7% [adjusted rate difference, -65.8% {95% CI, -76.6% to -49.8%}], P < .001). Beyond hypophosphatemia and increased parathyroid hormone, the most common adverse drug reactions (No./total No.) were nausea (iron isomaltoside: 1/125; ferric carboxymaltose: 8/117) and headache (iron isomaltoside: 4/125; ferric carboxymaltose: 5/117). Conclusions and Relevance: In 2 randomized trials of patients with iron-deficiency anemia who were intolerant of or unresponsive to oral iron, iron isomaltoside (now called ferric derisomaltose), compared with ferric carboxymaltose, resulted in lower incidence of hypophosphatemia over 35 days. However, further research is needed to determine the clinical importance of this difference. Trial Registration: ClinicalTrials.gov Identifiers: NCT03238911 and NCT03237065.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Xeno发布了新的文献求助10
刚刚
NexusExplorer的应助被科研通管家采纳,获得10
1秒前
汉堡包的应助被科研通管家采纳,获得10
1秒前
秋风的应助被科研通管家采纳,获得10
1秒前
yiyi1发布了新的文献求助20
1秒前
1秒前
1秒前
JamesPei的应助被科研通管家采纳,获得10
1秒前
1秒前
852的应助被科研通管家采纳,获得10
1秒前
Owen的应助被科研通管家采纳,获得50
1秒前
wanghongyue发布了新的文献求助10
1秒前
英俊的铭的应助被科研通管家采纳,获得10
1秒前
1秒前
2秒前
Lucas的应助被科研通管家采纳,获得10
2秒前
风吹麦浪的应助被科研通管家采纳,获得10
2秒前
脑洞疼的应助被科研通管家采纳,获得10
2秒前
Rita的应助被科研通管家采纳,获得10
2秒前
华仔的应助被zz采纳,获得10
2秒前
null的应助被科研通管家采纳,获得10
2秒前
Hello的应助被洛可可采纳,获得10
2秒前
DW的应助被科研通管家采纳,获得10
2秒前
LY完成签到,获得积分20
2秒前
ccq的应助被科研通管家采纳,获得10
3秒前
3秒前
3秒前
3秒前
4秒前
4秒前
9465426发布了新的文献求助10
4秒前
jyg123456完成签到 ,获得积分10
4秒前
ZX发布了新的文献求助10
4秒前
5秒前
芊芊发布了新的文献求助10
5秒前
5秒前
liuqingqing发布了新的文献求助10
5秒前
wanci的应助被任尔采纳,获得10
5秒前
尊敬孤兰发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177849
求助须知:如何正确求助?哪些是违规求助? 9568641
关于积分的说明 21800145
捐赠科研通 7772473
什么是DOI,文献DOI怎么找? 3432537
关于科研通互助平台的介绍 2556720
邀请新用户注册赠送积分活动 2478067